Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies - 17/06/23
, Yangxi Liu a, 1 , Zhenzhen Li b , Shaoling Feng a , Shanshan Lin a , Zhao Ge a , Yujian Fan a , Yi Wang b, ⁎ , Xianliang Wang a, ⁎ , Jingyuan Mao a, ⁎ Abstract |
Coronary microvascular dysfunction (CMD) is a high-risk factor for a variety of cardiovascular events. Due to its complex aetiology and concealability, knowledge of the pathophysiological mechanism of CMD is still limited at present, which greatly restricts its clinical diagnosis and treatment. Studies have shown that CMD is closely related to a variety of cardiovascular diseases, can aggravate the occurrence and development of cardiovascular diseases, and is closely related to a poor prognosis in patients with cardiovascular diseases. Improving coronary microvascular remodelling and increasing myocardial perfusion might be promising strategies for the treatment of cardiovascular diseases. In this paper, the pathogenesis and functional assessment of CMD are reviewed first, along with the relationship of CMD with cardiovascular diseases. Then, the latest strategies for the treatment of CMD and cardiovascular diseases are summarized. Finally, urgent scientific problems in CMD and cardiovascular diseases are highlighted and future research directions are proposed to provide prospective insights for the prevention and treatment of CMD and cardiovascular diseases in the future.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | CMD is a multifactorial disease, prevalent in a wide spectrum of clinical cardiovascular situations. |
• | The diagnosis, evaluation and treatment of CMD still face great challenges. |
• | Improving CMD might be a promising strategy for the treatment of cardiovascular diseases. |
• | CMD is of great clinical significance, but there are still many research gaps. |
Abbreviations : CMD, CBF, DCM, CAG, OCAD, INOCA, MINOCA, HFpEF, HCM, CHM, CMECs, CFR, IMR, NO, MBF, SPECT, PET, CMR, TTDE, MCE, PCI, STEMI, MVA, VSA, NOCAD, ACEI, ARB, CCB, SGLT2, PDE, GLP-1, MACE
Keywords : Coronary microvascular dysfunction, Cardiovascular disease, Coronary flow reserve, Index of microcirculatory resistance, Pathogenesis, Treatment strategies
Plan
Vol 164
Article 115011- août 2023 Retour au numéro
Article précédent
- Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol
- Rong Ma, Danni Lu, Jian Wang, Qian Xie, Jialiang Guo
- Evaluation of the association of chronic inflammation and cancer: Insights and implications
- Manisha Nigam, Abhay Prakash Mishra, Vishal Kumar Deb, Deen Bandhu Dimri, Vinod Tiwari, Simona Gabriela Bungau, Alexa Florina Bungau, Andrei-Flavius Radu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?